active ingredient

(redirected from Active pharmaceutical ingredients)

Active Ingredient

Any component that provides pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or affects the structure or any function of the body of man or animals.

ac·tive in·gre·di·ent

(ak'tiv in-grē'dē-ĕnt)
Any component of a pharmaceutical product that exerts pharmacologic activity.
Synonym(s): active pharmaceutical ingredient.

active ingredient

the chemically active part of a manufactured product such as a HERBICIDE, the remainder being inert.
References in periodicals archive ?
Sales volume of active pharmaceutical ingredients in the first six months of 2019 reached EUR 5.1 million which is by EUR 0.81 million or 19 percent more than in the first six months of 2018.
27 August 2019 - Massachusetts, US-based synthetic biology company Conagen has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins, to enhance development of active pharmaceutical ingredients, the company said.
M2 PRESSWIRE-August 19, 2019-: Active Pharmaceutical Ingredients Market 2019 Global Trends, Size, Share, Regional Analysis by Key Players, Emerging Technology, Industry Forecast by Type, API Formulation and Application
Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients.
TDF, one of the active pharmaceutical ingredients in Truvada, Atripla, Complera/Eviplera and Stribild, faces generic competition in the European Union, the United States and certain other countries.
28 January 2019 - Italian active pharmaceutical ingredients contract development and manufacturing organisation and generics supplier Olon S.p.A.
Based in Rancho Cordova, CA, AFC is a global supplier of high value-added active pharmaceutical ingredients and intermediates used in treating diseases such as cancer, CNS disorders and various viral infections.
If you're involved in the manufacture, use or distribution of active pharmaceutical ingredients (APIs) anywhere in the supply chain, take note: The FDA recently released a new set of questions and answers for its guidance, Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients.
government, are manufactured by Aurolife Pharma in Dayton, N.J., using active pharmaceutical ingredients or APIs from India.
BioVectra is a CDMO that serves pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients. The company specializes in GMP microbial fermentation and purification, complex chemistry, and process and analytical development.
The technology is poised to open up new branches of Active Pharmaceutical Ingredients (APIs) that previously could not withstand traditional spray drying, as well as in nano-particle technology where complete microencapsulation is critical.